# Quagen Pharmaceuticals LLC – FDA Inspection, Nov 8, 2023

Source: https://www.keypedia.com/records/fda_inspections/quagen-pharmaceuticals-llc/22c15808-cc5c-4265-a46e-d62b2a6a69ea
Source feed: FDA_Inspections

> FDA inspection 1222389 of Quagen Pharmaceuticals LLC, November 08, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222389
- Company Name: Quagen Pharmaceuticals LLC
- Inspection Date: 2023-11-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1322648 - 2026-05-19
- [FDA Inspection 1194335 - 2022-12-19](https://www.keypedia.com/records/fda_inspections/quagen-pharmaceuticals-llc/3a1b6eac-9184-4d2e-b6aa-a723c03b5fdf)
- FDA Inspection 1085743 - 2019-03-15

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)
- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/quagen-pharmaceuticals-llc/9f3a6bdf-7084-4753-aa36-3a336180eb8d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c